ITRM20050064A1 - Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative. - Google Patents

Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.

Info

Publication number
ITRM20050064A1
ITRM20050064A1 IT000064A ITRM20050064A ITRM20050064A1 IT RM20050064 A1 ITRM20050064 A1 IT RM20050064A1 IT 000064 A IT000064 A IT 000064A IT RM20050064 A ITRM20050064 A IT RM20050064A IT RM20050064 A1 ITRM20050064 A1 IT RM20050064A1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
timidilato
sintetasi
poliepitopic
immunological
Prior art date
Application number
IT000064A
Other languages
English (en)
Inventor
Pierpaolo Correale
Maria Grazia Cusi
Guido Francini
Giorgio Giorgi
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena filed Critical Univ Siena
Priority to IT000064A priority Critical patent/ITRM20050064A1/it
Priority to PCT/IT2006/000078 priority patent/WO2006087756A2/en
Priority to MX2007009896A priority patent/MX2007009896A/es
Priority to DE602006019057T priority patent/DE602006019057D1/de
Priority to AU2006215260A priority patent/AU2006215260B2/en
Priority to ES06711432T priority patent/ES2357548T3/es
Priority to EP06711432A priority patent/EP1848456B1/en
Priority to AT06711432T priority patent/ATE492286T1/de
Priority to RU2007134338/13A priority patent/RU2007134338A/ru
Priority to US11/814,919 priority patent/US8344100B2/en
Priority to CNA2006800079661A priority patent/CN101137392A/zh
Priority to JP2007554746A priority patent/JP4943348B2/ja
Priority to CA2598292A priority patent/CA2598292C/en
Priority to NZ560511A priority patent/NZ560511A/en
Publication of ITRM20050064A1 publication Critical patent/ITRM20050064A1/it
Priority to IL185101A priority patent/IL185101A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT000064A 2005-02-16 2005-02-16 Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative. ITRM20050064A1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT000064A ITRM20050064A1 (it) 2005-02-16 2005-02-16 Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.
AT06711432T ATE492286T1 (de) 2005-02-16 2006-02-15 Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität
RU2007134338/13A RU2007134338A (ru) 2005-02-16 2006-02-15 Полиэпитопный пептид иммунологической и противоопухолевой активностью, полученный из тимидилатсинтазы
DE602006019057T DE602006019057D1 (de) 2005-02-16 2006-02-15 Poly-epitop peptid abgeleitet aus der thymidylat-synthase mit immunologischer und anti-tumor aktivität
AU2006215260A AU2006215260B2 (en) 2005-02-16 2006-02-15 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
ES06711432T ES2357548T3 (es) 2005-02-16 2006-02-15 Péptido poli-epitope derivado de timidilato sintasa que tiene actividad inmunológica y antitumoral.
EP06711432A EP1848456B1 (en) 2005-02-16 2006-02-15 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
PCT/IT2006/000078 WO2006087756A2 (en) 2005-02-16 2006-02-15 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
MX2007009896A MX2007009896A (es) 2005-02-16 2006-02-15 Peptido poliepitopico derivado de timidilato sintetasa que tiene actividad inmunologica y antitumoral.
US11/814,919 US8344100B2 (en) 2005-02-16 2006-02-15 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
CNA2006800079661A CN101137392A (zh) 2005-02-16 2006-02-15 来源于胸苷酸合酶的、具有免疫学和抗肿瘤活性的多表位肽
JP2007554746A JP4943348B2 (ja) 2005-02-16 2006-02-15 免疫学的及び抗腫瘍活性を有するチミジル酸シンターゼ由来のポリエピトープペプチド
CA2598292A CA2598292C (en) 2005-02-16 2006-02-15 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
NZ560511A NZ560511A (en) 2005-02-16 2006-02-15 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
IL185101A IL185101A0 (en) 2005-02-16 2007-08-07 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000064A ITRM20050064A1 (it) 2005-02-16 2005-02-16 Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.

Publications (1)

Publication Number Publication Date
ITRM20050064A1 true ITRM20050064A1 (it) 2006-08-17

Family

ID=36604211

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000064A ITRM20050064A1 (it) 2005-02-16 2005-02-16 Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.

Country Status (15)

Country Link
US (1) US8344100B2 (it)
EP (1) EP1848456B1 (it)
JP (1) JP4943348B2 (it)
CN (1) CN101137392A (it)
AT (1) ATE492286T1 (it)
AU (1) AU2006215260B2 (it)
CA (1) CA2598292C (it)
DE (1) DE602006019057D1 (it)
ES (1) ES2357548T3 (it)
IL (1) IL185101A0 (it)
IT (1) ITRM20050064A1 (it)
MX (1) MX2007009896A (it)
NZ (1) NZ560511A (it)
RU (1) RU2007134338A (it)
WO (1) WO2006087756A2 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20050064A1 (it) 2005-02-16 2006-08-17 Univ Siena Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.
EA018457B1 (ru) * 2007-07-27 2013-08-30 Имматикс Байотекнолоджиз Гмбх Композиция опухолеассоциированных пептидов и относящаяся к ним противораковая вакцина
WO2010138955A2 (en) 2009-05-29 2010-12-02 University Of Florida Research Foundation, Inc. Methods and compositions for treating neoplasia
CN101948508B (zh) * 2010-09-09 2012-07-04 郑州大学 Piwil2抗肿瘤ctl表位肽及其应用
RU2507265C2 (ru) * 2012-05-12 2014-02-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической иммунологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИКИ" СО РАМН) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pCI-UB-POLYEPI, СОДЕРЖАЩАЯ ЭПИТОПЫ ОПУХОЛЬ-АССОЦИИРОВАННЫХ АНТИГЕНОВ ДЛЯ КОЛОРЕКТАЛЬНОГО РАКА, И СПОСОБ ЕЕ ПРИМЕНЕНИЯ ДЛЯ СТИМУЛЯЦИИ СПЕЦИФИЧЕСКОГО ПРОТИВООПУХОЛЕВОГО ИММУННОГО ОТВЕТА ПРОТИВ КЛЕТОК КОЛОРЕКТАЛЬНОГО РАКА
CN113827740A (zh) * 2021-09-17 2021-12-24 青岛农业大学 一种水溶性复合疫苗佐剂的筛选方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US7462354B2 (en) * 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
ITRM20050064A1 (it) 2005-02-16 2006-08-17 Univ Siena Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.

Also Published As

Publication number Publication date
JP4943348B2 (ja) 2012-05-30
NZ560511A (en) 2010-07-30
JP2008529522A (ja) 2008-08-07
DE602006019057D1 (de) 2011-02-03
MX2007009896A (es) 2008-02-12
US20080305091A1 (en) 2008-12-11
CA2598292A1 (en) 2006-08-24
WO2006087756A2 (en) 2006-08-24
AU2006215260A1 (en) 2006-08-24
WO2006087756A3 (en) 2006-11-02
IL185101A0 (en) 2007-12-03
CN101137392A (zh) 2008-03-05
RU2007134338A (ru) 2009-03-27
AU2006215260B2 (en) 2011-04-28
US8344100B2 (en) 2013-01-01
ATE492286T1 (de) 2011-01-15
EP1848456A2 (en) 2007-10-31
CA2598292C (en) 2017-04-04
EP1848456B1 (en) 2010-12-22
ES2357548T3 (es) 2011-04-27

Similar Documents

Publication Publication Date Title
BR0209489A (pt) Composições farmacêuticas
DE50306232D1 (de) Ampholytisches copolymer und dessen verwendung
FR2894585B1 (fr) Copolymere comprenant des unites zwitterioniques et d'autres unites, composition comprenant le copolymere, et utilisation
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
JO2578B1 (en) Compounds Theophene benzimidazole
MX336807B (es) Composiciones y metodos para producir una composicion.
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
MX337147B (es) Composiciones y metodos para utilizar peptidos proislet y sus analogos.
PL1910338T3 (pl) Związki heterotetracykliczne jako mimetyki TPO
IT1320080B1 (it) Composizione per uso farmaceutico o dietetico.
TW200731974A (en) Transdermal system for verenicline
BRPI0606687A2 (pt) composições nutracêuticas
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
MX2008002166A (es) Compuestos y composiciones como mimeticos de trombopoietina (tpo).
IL185101A0 (en) Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
BRPI0417950A (pt) composições farmacêuticas
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
TW200621160A (en) Anti-termite agent
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
MY163037A (en) Endoparasiticidal compositions
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
DE60041198D1 (de) Antimikrobielle zusammensetzungen
SI1720540T1 (sl) Satraplatin za zdravljenje rezistentnih ali refraktornih tumorjev
TNSN07300A1 (en) 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents